Alnylam To Webcast Presentations At Upcoming February Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the 18th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2016 at 3:00 pm ET as well as the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016 at 1:25 pm ET, both at the Waldorf Astoria in New York City.